| A human genome diversity cell line panel HM Cann, C De Toma, L Cazes, MF Legrand, V Morel, L Piouffre, ... Science 296 (5566), 261-262, 2002 | 1140 | 2002 |
| CTLA‐4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction E Contardi, GL Palmisano, PL Tazzari, AM Martelli, F Fala, M Fabbi, ... International journal of cancer 117 (4), 538-550, 2005 | 336 | 2005 |
| Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma E Simeone, G Gentilcore, D Giannarelli, AM Grimaldi, C Caracò, ... Cancer immunology, immunotherapy 63, 675-683, 2014 | 265 | 2014 |
| The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production S Laurent, P Queirolo, S Boero, S Salvi, P Piccioli, S Boccardo, ... Journal of translational medicine 11 (1), 1-13, 2013 | 155 | 2013 |
| CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells MP Pistillo, PL Tazzari, GL Palmisano, I Pierri, A Bolognesi, F Ferlito, ... Blood, The Journal of the American Society of Hematology 101 (1), 202-209, 2003 | 148 | 2003 |
| Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer S Salvi, V Fontana, S Boccardo, DF Merlo, E Margallo, S Laurent, ... Cancer Immunology, Immunotherapy 61, 1463-1472, 2012 | 145 | 2012 |
| MicroRNA in glioblastoma: an overview B Banelli, A Forlani, G Allemanni, A Morabito, MP Pistillo, M Romani International journal of genomics 2017, 2017 | 140 | 2017 |
| CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions S Laurent, P Carrega, D Saverino, P Piccioli, M Camoriano, A Morabito, ... Human immunology 71 (10), 934-941, 2010 | 109 | 2010 |
| Lack of HLA‐class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression MV Corrias, M Occhino, M Croce, A De Ambrosis, MP Pistillo, P Bocca, ... Tissue antigens 57 (2), 110-117, 2001 | 85 | 2001 |
| Epigenetic targeting of glioblastoma M Romani, MP Pistillo, B Banelli Frontiers in oncology 8, 448, 2018 | 81 | 2018 |
| Immune checkpoints and innovative therapies in glioblastoma M Romani, MP Pistillo, R Carosio, A Morabito, B Banelli Frontiers in oncology 8, 464, 2018 | 78 | 2018 |
| HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines GL Palmisano, E Contardi, A Morabito, V Gargaglione, GB Ferrara, ... Human immunology 66 (1), 1-12, 2005 | 74 | 2005 |
| Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors P Ferro, MC Franceschini, B Bacigalupo, P Dessanti, E Falco, V Fontana, ... Anticancer research 30 (6), 2377-2382, 2010 | 69 | 2010 |
| Environmental epigenetics: crossroad between public health, lifestyle, and cancer prevention M Romani, MP Pistillo, B Banelli BioMed research international 2015, 2015 | 66 | 2015 |
| Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study MP Pistillo, V Fontana, A Morabito, B Dozin, S Laurent, R Carosio, ... Cancer Immunology, Immunotherapy 68, 97-107, 2019 | 63 | 2019 |
| Association of− 318 C/T and+ 49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis G Balbi, F Ferrera, M Rizzi, P Piccioli, A Morabito, L Cardamone, M Ghio, ... Clinical & Experimental Immunology 149 (1), 40-47, 2007 | 59 | 2007 |
| Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study P Queirolo, A Morabito, S Laurent, S Lastraioli, P Piccioli, PA Ascierto, ... Cancer investigation 31 (5), 336-345, 2013 | 58 | 2013 |
| Investigation of HLA class I downregulation in breast cancer by RT-PCR GL Palmisano, MP Pistillo, P Capanni, C Pera, G Nicolò, S Salvi, ... Human immunology 62 (2), 133-139, 2001 | 58 | 2001 |
| Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model PL Tazzari, L Polito, A Bolognesi, MP Pistillo, P Capanni, GL Palmisano, ... The Journal of Immunology 167 (8), 4222-4229, 2001 | 57 | 2001 |
| Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells B Banelli, A Daga, A Forlani, G Allemanni, D Marubbi, MP Pistillo, ... Oncotarget 8 (21), 34896, 2017 | 49 | 2017 |
